Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Gabapentin NDC 0904-6823 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
e6746052 be65 4002 b833 4b2a140b92ef 00
This is a description of a medication called Gabapentin in a Unit Dose package of 100 tablets. The pharmacist is instructed to dispense it with a medication guide, and it is only available with a prescription. The tablets contain 300mg of Gabapentin USP and the dosage instructions can be found on the product insert or prescribing information. The medication should be stored between 0°C and 25°C and kept out of reach of children. The package is not child-resistant and should be used up to completion.*
e6746052 be65 4002 b833 4b2a140b92ef 01
This is a label of Gabapentin Tablets, USP by Major Pharmaceuticals which contains 100 tablets in a unit dose packaging. It has an NDC number of 0904-6823-61 and it can only be dispensed by a pharmacist with a medication guide. The label includes information on storage instructions and a website link to the manufacturer's website. No information is available on the dosage, indications or side-effects of the medication.*
Creatinine clearance - gabapentin fig1
This appears to be a formula for calculating a value called "Lt" using a person's age and weight (in kilograms) multiplied by a factor of 140, and then diving the result by their creatinine level (in grams). The formula specifies that a creatinine value of 0.85 should be used for female patients. It is not clear what this value represents or how it is used in a medical context.*
Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - gabapentin fig2
The text is a caption for a figure showing weekly mean pain scores observed in a study. The study compared the effects of a placebo and Gabapentin (at a dosage of 300 mg/day) on pain. The figure shows the pain scores for each week along with markers for the mean pain score for each treatment group. The text includes some jumbled characters and does not provide any additional information.*
Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - gabapentin fig3
Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4
Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5
This appears to be a table or chart that is not readable, most likely it is not available.*
Chemical Structure - gabapentin str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.